<
https://www.theguardian.com/society/2024/apr/26/cancer-mrna-vaccine-melanoma-trial>
"Doctors have begun trialling in hundreds of patients the world’s first
personalised mRNA cancer vaccine for melanoma, as experts hailed its
“gamechanging” potential to permanently cure cancer.
Melanoma affects about 132,000 people a year globally and is the biggest skin
cancer killer. Currently, surgery is the main treatment although radiotherapy,
medicines and chemotherapy are also sometimes used.
Now experts are testing new jabs that are custom-built for each patient and
tell their body to hunt down cancer cells to prevent the disease ever coming
back.
A phase 2 trial found the vaccines dramatically reduced the risk of the cancer
returning in melanoma patients. Now a final, phase 3, trial has been launched
and is being led by University College London Hospitals NHS Foundation Trust
(UCLH).
Dr Heather Shaw, the national coordinating investigator for the trial, said the
jabs had the potential to cure people with melanoma and are being tested in
other cancers, including lung, bladder and kidney.
“This is one of the most exciting things we’ve seen in a really long time,”
said Shaw. “This is a really finely honed tool. To be able to sit there and say
to your patients that you’re offering them something that’s effectively like
the Fat Duck at Bray versus McDonald’s – it’s that level of cordon bleu that’s
coming to them … The patients are really excited about them.”
The vaccine is an individualised neoantigen therapy. It is designed to trigger
the immune system so it can fight back against a patient’s specific type of
cancer and tumour."
Via
What Could Go Right?: They Rich Rich?
https://theprogressnetwork.org/young-americans-high-wealth/
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
